Perioperative Tislelizumab with Four Cycles of Neoadjuvant Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Phase 2 Study
FRONTIERS IN IMMUNOLOGY（2024）
关键词
esophageal squamous cell carcinoma,perioperative treatment,tislelizumab,immunotherapy,neoadjuvant chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要